ARTICLE | Company News
Elan and Neurome in Alzheimer's deal
October 20, 2000 7:00 AM UTC
Neurome (La Jolla, Calif.) will use ELN's amyloid deposition mouse model of Alzheimer's to identify and exploit molecules and pathways for the treatment and diagnosis of the disease. Neurome will rece...